Evidence map›Paper›PMID 26138224›Full record

ArticleScientific reports2015

In vivo bioimaging with tissue-specific transcription factor activated luciferase reporters.

Suzanne M K Buckley, Juliette M K M Delhove, Dany P Perocheau, Rajvinder Karda, Ahad A Rahim, Steven J Howe, Natalie J Ward, Mark A Birrell, Maria G Belvisi, Patrick Arbuthnot and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. A Novel SmallCells · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. AniScience · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Engineering molecular imaging strategies for regenerative medicine.Bioengineering & translational medicine · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Suzanne M K BuckleyGene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK.
Juliette M K M Delhove1] Stem Cell Group, Cardiovascular &Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK [2] Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Dany P PerocheauGene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK.
Rajvinder Karda1] Gene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK [2] Faculty of Medicine, Department of Surgery &Cancer, Imperial College, London, UK.
Ahad A RahimDepartment of Pharmacology, School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK.
Steven J HoweWolfson Institute for Gene Therapy, Molecular and Cellular Immunology, Institute of Child Health, University College London, London WC1N 1EH, UK.
Natalie J WardGene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK.
Mark A BirrellFaculty of Medicine, National Heart &Lung Institute, Imperial College, London, UK.
Maria G BelvisiFaculty of Medicine, National Heart &Lung Institute, Imperial College, London, UK.
Patrick ArbuthnotWits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Mark R JohnsonFaculty of Medicine, Department of Surgery &Cancer, Imperial College, London, UK.
Simon N Waddington1] Gene Transfer Technology Group, Institute for Women's Health, University College London, 86-96 Chenies Mews, London WC1E 6HX, UK [2] Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Tristan R McKayStem Cell Group, Cardiovascular &Cell Sciences Research Institute, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK.
University College London · GBImperial College London · GBNational Institutes of Health · USSt George's, University of London · GBUniversity of the Witwatersrand · ZA

Funding

Medical Research Council G1000709National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/L001780/1
6 · The paper itself

Abstract

The application of transcription factor activated luciferase reporter cassettes in vitro is widespread but potential for in vivo application has not yet been realized. Bioluminescence imaging enables non-invasive tracking of gene expression in transfected tissues of living rodents. However the mature immune response limits luciferase expression when delivered in adulthood. We present a novel approach of tissue-targeted delivery of transcription factor activated luciferase reporter lentiviruses to neonatal rodents as an alternative to the existing technology of generating germline transgenic light producing rodents. At this age, neonates acquire immune tolerance to the conditionally responsive luciferase reporter. This simple and transferrable procedure permits surrogate quantitation of transcription factor activity over the lifetime of the animal. We show principal efficacy by temporally quantifying NFκB activity in the brain, liver and lungs of somatotransgenic reporter mice subjected to lipopolysaccharide (LPS)-induced inflammation. This response is ablated in Tlr4(-/-) mice or when co-administered with the anti-inflammatory glucocorticoid analogue dexamethasone. Furthermore, we show the malleability of this technology by quantifying NFκB-mediated luciferase expression in outbred rats. Finally, we use somatotransgenic bioimaging to longitudinally quantify LPS- and ActivinA-induced upregulation of liver specific glucocorticoid receptor and Smad2/3 reporter constructs in somatotransgenic mice, respectively.

Indexed as

AnimalsGenes, ReporterGenetic VectorsGreen Fluorescent ProteinsHEK293 CellsHeLa CellsHumansLentivirusLipopolysaccharidesLuciferases, FireflyMiceNIH 3T3 CellsOrgan SpecificityRats, Sprague-DawleyRecombinant Fusion ProteinsTranscriptional Activationenhanced green fluorescent proteinGreen Fluorescent ProteinsLipopolysaccharidesLuciferases, FireflyRecombinant Fusion ProteinsTranscription Factors

Identifiers

PMID26138224
PMCPMC4490336
OpenAlexW828817059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.